Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

501
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
501
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

380
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
380
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

474
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
474

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifts in Incident Glucose Lowering Drug Initiation in Type 2 Diabetes From 2014 to 2024: A Population-Based Study.

Diabetes, obesity & metabolism·2026
Same author

Predicting device-related complications among women undergoing breast implant surgeries.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes: Outcomes of a Population-Based Real-World Study.

Diabetes technology & therapeutics·2026
Same author

Geographic Variation in Loneliness and Social Isolation in Australia: Socio-Demographic and Healthcare Utilisation Determinants.

Healthcare (Basel, Switzerland)·2026
Same author

Comorbidities/cardiovascular risk factors and acute glycaemic emergencies in patients with type 1 and type 2 diabetes: The Australian National Diabetes Audit.

Diabetes research and clinical practice·2026
Same author

Derivation of an updated brief multivariable prediction model to detect panic-related anxiety in emergency department patients with cardiopulmonary complaints.

Frontiers in psychiatry·2026

Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

915

A multi-level spatio-temporal analysis on prostate cancer outcomes.

Win Wah1, Nathan Papa1, Melanie Evans1

  • 1Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Cancer Epidemiology
|April 16, 2021
PubMed
Summary

Positive surgical margins (PSM) after prostate cancer surgery are linked to higher mortality. Aggressive tumors and surgical techniques significantly influence PSM rates, highlighting areas for improved patient outcomes.

Keywords:
All-cause mortalityMulti-levelPositive surgical marginProstate cancerSpatial-temporal

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.5K

Related Experiment Videos

Last Updated: Nov 9, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

915
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.5K

Area of Science:

  • Urology
  • Surgical Oncology
  • Health Services Research

Background:

  • Geographic and temporal variations in positive surgical margins (PSM) after radical prostatectomy (RP) for prostate cancer are documented.
  • Factors contributing to these variations, including patient, surgeon, institutional, and socioeconomic elements, remain unclear.
  • The impact of PSM on mortality for localized prostate cancer patients requires further investigation.

Purpose of the Study:

  • To assess the independent and relative contributions of patient, surgeon, institutional, and area-level risk factors to geographic and temporal variations in PSM.
  • To evaluate the impact of PSM on five-year all-cause and prostate cancer-specific mortality in localized prostate cancer patients.

Main Methods:

  • Utilized Bayesian spatial-temporal multi-level models to analyze individual and area-level data from 10,075 localized prostate cancer cases (2009-2018).
  • Incorporated patient demographics, tumor characteristics (NCCN risk), RP techniques, surgeon/institution factors, and socioeconomic data.
  • Accounted for spatial and temporal correlations and non-linear trends.

Main Results:

  • 26% of patients had PSM, with significant geographic and temporal variations.
  • Higher likelihood of PSM was associated with intermediate/high-risk NCCN groups, public surgical institutions, and socioeconomic disadvantage.
  • Robot-assisted, laparoscopic RP, high-volume surgeons, and socioeconomic advantage were associated with lower PSM rates.
  • PSM independently predicted higher five-year all-cause and prostate cancer-specific mortality.

Conclusions:

  • Aggressive tumor characteristics and specific RP techniques are primary drivers of PSM.
  • Reducing PSM prevalence is crucial for improving overall and prostate cancer-specific survival rates.